| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Colorectal cancer special, part 2
|
Gerger, Armin
|
|
|
16 |
2 |
p. 93
|
artikel
|
| 2 |
ESMO 2022
|
Bartsch, Rupert
|
|
|
16 |
2 |
p. 91-92
|
artikel
|
| 3 |
ESMO 2022 personal non-small lung cancer (NSCLC) highlights
|
Horvath, Lena
|
|
|
16 |
2 |
p. 97-99
|
artikel
|
| 4 |
ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors
|
Mair, Maximilian J.
|
|
|
16 |
2 |
p. 100-104
|
artikel
|
| 5 |
ESMO update: upper gastrointestinal cancer
|
Bergen, Elisabeth S.
|
|
|
16 |
2 |
p. 105-107
|
artikel
|
| 6 |
Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report
|
Petrasch, Clemens
|
|
|
16 |
2 |
p. 122-124
|
artikel
|
| 7 |
Immunotherapy for metastatic melanoma—from little benefit to first-line treatment
|
Mutz-Rabl, Christiane G.
|
|
|
16 |
2 |
p. 108-112
|
artikel
|
| 8 |
Lessons learned in adjuvant colorectal cancer
|
Schmalfuss, Theresa
|
|
|
16 |
2 |
p. 113-115
|
artikel
|
| 9 |
Molecular pathology of colorectal cancer
|
Noack, Petar
|
|
|
16 |
2 |
p. 116-121
|
artikel
|
| 10 |
Neoadjuvant and adjuvant therapy in early breast cancer. A short review on current clinical approaches
|
Udovica, Simon
|
|
|
16 |
2 |
p. 125-128
|
artikel
|
| 11 |
Position paper on CDK4/6 inhibitors in early breast cancer
|
Gnant, Michael
|
|
|
16 |
2 |
p. 135-144
|
artikel
|
| 12 |
Selection of phase II/III breast cancer study highlights at the 2022 ESMO annual meeting
|
Marhold, Maximilian
|
|
|
16 |
2 |
p. 94-96
|
artikel
|
| 13 |
Spectrum of renal involvement in MGRS patients: a 6-year study
|
Tadkal, Poornima
|
|
|
16 |
2 |
p. 129-134
|
artikel
|
Tijdschrift beschrijving